PDL BioPharma shares are trading higher after Silver Point Capital disclosed the purchase of 1.565 million shares.
PDL BioPharma shares are trading higher after Silver Point Capital disclosed the purchase of 1.565 million shares.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.